Skip to main content

Table 3 HIV risks among transgender women who reported always and not always using condoms with male non-commercial partners (n = 1202)

From: Factors associated with condom use with non-commercial partners among sexually-active transgender women in Cambodia: findings from a national survey using respondent-driven sampling

HIV risks

  

Condom use with male non-commercial partner in the past three months

Crude n (%)

RDS-adjusted % (95% CI)

RDS-adjusted % (always)

RDS-adjusted % (not always)

P-value*

Main role in anal sex with men in the past 12 months

Insertive

26 (2.2)

2.0 (1.0, 2.9)

2.9

1.3

0.32

Receptive

1043 (86.8)

85.7 (82.8, 88.6)

84.9

85.9

 

Both

133 (11.1)

12.3 (9.5, 15.1)

12.3

12.7

 

Had sex with male commercial partners in the past 3 months

444 (36.9)

34.0 (29.6, 38.3)

33.3

36.3

0.43

Had ≥2 male commercial partners in the past 3 months

310 (25.8)

22.5 (19.1, 25.9)

21.5

24.3

0.42

Always used condoms with male commercial partners

243 (20.2)

17.6 (14.1, 21.0)

14.1

24.9

< 0.001

Had an STI symptom in the past 12 months

175 (14.6)

14.7 (11.5, 17.8)

11.3

17.6

0.005

Tested for HIV in the past 6 months

617 (51.3)

42.9 (37.9, 47.8)

51.6

43.8

0.04

Perceived likelihood of HIV infection

Very Likely

128 (10.7)

7.0 (5.4, 8.6)

6.2

9.8

< 0.001

Likely

693 (57.7)

58.0 (54.0, 62.0)

48.5

63.3

 

Unlikely

293 (24.4)

27.1 (23.4, 30.8)

33.8

19.8

 

Very Unlikely

88 (7.3)

7.9 (5.9, 10.0)

9.9

5.3

 
  1. Abbreviations: CI confidence interval, HIV human immunodeficiency virus, RDS respondent driven sampling, STI sexually transmitted infections
  2. * Chi-square test (or Fisher’s exact test when a cell count was smaller than 5) was used